Get started
Author

Franćoise Lejeune

Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents
2000 · Mark J. Millan, Françoise Lejeune, et al. · Journal of Psychopharmacology · 229
S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models
2008 · Anne Dekeyne, Clotilde Mannoury la Cour, et al. · Psychopharmacology · 131
A Comparative In Vitro and In Vivo Pharmacological Characterization of the Novel Dopamine D3Receptor Antagonists (+)-S 14297, Nafadotride, GR 103,691 and U 99194
1998 · Valérie Audinot, Adrian Newman-Tancredi, et al. · Journal of Pharmacology and Experimental Therapeutics · 128
S33084, a Novel, Potent, Selective, and Competitive Antagonist at Dopamine D3-Receptors: I. Receptorial, Electrophysiological and Neurochemical Profile Compared with GR218,231 and L741,626
2000 · Mark J. Millan, Alain Gobert, et al. · Journal of Pharmacology and Experimental Therapeutics · 122
S18616, a Highly Potent Spiroimidazoline Agonist at α2-Adrenoceptors: II. Influence on Monoaminergic Transmission, Motor Function, and Anxiety in Comparison with Dexmedetomidine and Clonidine
2000 · Mark J. Millan, Françoise Lejeune, et al. · Journal of Pharmacology and Experimental Therapeutics · 89
S 18126 ({2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl}), a Potent, Selective and Competitive Antagonist at Dopamine D4 Receptors: An In Vitro and In Vivo Comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2,3b]pyridine) and Raclopride
1998 · Mark J. Millan, Adrian Newman-Tancredi, et al. · Journal of Pharmacology and Experimental Therapeutics · 74
Selective blockade of neurokinin (NK)1 receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in rats
2001 · Mark J. Millan, Françoise Lejeune, et al. · Journal of Neurochemistry · 65
Activation of dopamine D3 autoreceptors inhibits firing of ventral tegmental dopaminergic neurones in vivo
1995 · Françoise Lejeune, Mark J. Millan · European Journal of Pharmacology · 63
Clozapine inhibits serotoninergic transmission by an action at α1-adrenoceptors not at 5-HT1A receptors
1994 · Françoise Lejeune, Valérie Audinot, et al. · European Journal of Pharmacology · 56
S 15535: a highly selective benzodioxopiperazine 5-HT1A receptor ligand which acts as an agonist and an antagonist at presynaptic and postsynaptic sites respectively
1993 · Mark J. Millan, Jean-Michel Rivet, et al. · European Journal of Pharmacology · 54
S 14506: A novel, potent, high‐efficacy 5‐HT1A agonist and potential anxiolytic agent
1992 · Francis C. Colpaert, Wouter Koek, et al. · Drug Development Research · 52
Antiparkinsonian Agent Piribedil Displays Antagonist Properties at Native, Rat, and Cloned, Human α2-Adrenoceptors: Cellular and Functional Characterization
2001 · Mark J. Millan, Didier Cussac, et al. · Journal of Pharmacology and Experimental Therapeutics · 45
WAY 100,135 and (−)-tertatolol act as antagonists at both 5-HT1A autoreceptors and postsynaptic 5-HT1A receptors in vivo
1993 · Françoise Lejeune, Jean-Michel Rivet, et al. · European Journal of Pharmacology · 40
S33138 [N-[4-[2-[(3 aS,9 bR)-8-Cyano-1,3 a,4,9 b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3 H)-yl)-ethyl]phenylacetamide], a Preferential Dopamine D3 versus D2 Receptor Antagonist and Potential Antipsychotic Agent. II. A Neurochemical, Electrophysiological and Behavioral Characterization in Vivo
2007 · Mark J. Millan, Per Svenningsson, et al. · Journal of Pharmacology and Experimental Therapeutics · 38
The selective neurokinin (NK)1 antagonist, GR205,171, stereospecifically enhances mesocortical dopaminergic transmission in the rat: a combined dialysis and electrophysiological study
2002 · Françoise Lejeune, Alain Gobert, et al. · Brain Research · 33
Blockade of transmission at NMDA receptors facilitates the electrical and synthetic activity of ascending serotoninergic neurones
1994 · Françoise Lejeune, Alain Gobert, et al. · Brain Research · 32
The CRF1 receptor antagonist, DMP695, abolishes activation of locus coeruleus noradrenergic neurones by CRF in anesthetized rats
2003 · Françoise Lejeune, Mark J. Millan · European Journal of Pharmacology · 31
S32504, a Novel Naphtoxazine Agonist at Dopamine D3/D2 Receptors: I. Cellular, Electrophysiological, and Neurochemical Profile in Comparison with Ropinirole
2004 · Mark J. Millan, Didier Cussac, et al. · Journal of Pharmacology and Experimental Therapeutics · 28
Neurokinin1 Antagonists Potentiate Antidepressant Properties of Serotonin Reuptake Inhibitors, Yet Blunt Their Anxiogenic Actions: A Neurochemical, Electrophysiological, and Behavioral Characterization
2008 · Alain Gobert, Mauricette Brocco, et al. · Neuropsychopharmacology · 26
S41744, a dual neurokinin (NK)1 receptor antagonist and serotonin (5-HT) reuptake inhibitor with potential antidepressant properties: A comparison to aprepitant (MK869) and paroxetine
2010 · Mark J. Millan, Anne Dekeyne, et al. · European Neuropsychopharmacology · 19
S18327 (1-{2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a Novel, Potential Antipsychotic Displaying Marked Antagonist Properties at α1- and α2-Adrenergic Receptors: I. Receptorial, Neurochemical, and Electrophysiological Profile
2000 · Mark J. Millan, Alain Gobert, et al. · Journal of Pharmacology and Experimental Therapeutics · 10
S 14671: A novel naphthylpiperazane 5-HT1A agonist of high efficacy and exceptional in vivo potency
1991 · Mark J. Millan, Hervé Canton, et al. · European Journal of Pharmacology · 10
Works count: 22
Citation count: 1,375
H-index: 19
I10-index: 22
Year
Topic
Type